Markets:

Overview

News

Currencies

International

Treasuries

Entera Bio Ltd. - Ordinary Shares (NQ:ENTX)

2.990 +0.040 (+1.36%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Entera Bio Ltd. - Ordinary Shares

< Previous 1 2 3 Next >

Which stocks are moving on Monday? ↗

July 27, 2026

Via Chartmill

Curious about the most active stocks on Monday? ↗

July 27, 2026

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 27, 2026

Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular session. The company's market cap stands at $100.9 million. Gossamer Bio (NASDAQ:GOSS) shares moved...

Via Benzinga

Monday's session: top gainers and losers ↗

July 27, 2026

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

July 27, 2026

Via Chartmill

Entera Bio: Q1 Earnings Insights ↗

May 05, 2023

Via Benzinga

What's going on in today's after hours session ↗

June 22, 2026

Via Chartmill

Top movers analysis one hour before the close of the markets on 2026-06-22: top gainers and losers in today's session. ↗

June 22, 2026

Via Chartmill

Get insights into the top gainers and losers of Friday's after-hours session. ↗

May 08, 2026

Via Chartmill

ENTX Rallies As Insiders Buy Company Shares — Retail Hopes For ‘Exciting Days’ Ahead ↗

February 11, 2026

Entera Bio said that the company chairman Geno J. Germano bought shares, in addition to directors Steven D. Rubin, Haya Taitel, and Sean Ellis.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 15, 2025

Via Benzinga

Entera Bio Beats Q2 EPS Estimates ↗

August 08, 2025

Via The Motley Fool

Topics Intellectual Property

ENTX Stock Earnings: Entera Bio Meets EPS for Q2 2024 ↗

August 12, 2024

ENTX stock results show that Entera Bio met analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years ↗

July 23, 2024

These are the meme stocks to buy as they represent fundamentally strong ideas with major growth acceleration catalysts.

Via InvestorPlace

3 Meme Stocks That Can Surge by 200% Before 2025 ↗

July 08, 2024

Don't wait too long on these attractive meme stocks to buy for 200% upside, as they represent good businesses with growth catalysts.

Via InvestorPlace

3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns ↗

July 02, 2024

These are the clinical-stage biotech stocks to buy, as they represent companies with an attractive product pipeline.

Via InvestorPlace

3 Meme Stocks to Buy on the Dip: June 2024 ↗

June 25, 2024

Investors can't miss out on meme stocks to buy on the dip since these represent fundamentally sound ideas with growth acceleration catalysts

Via InvestorPlace

7 Penny Stocks to Turn $3 Into $1 Million Within 36 Months ↗

June 20, 2024

Wise investors consider penny stocks to buy which represent companies with vigorous fundamentals and a robust growth outlook.

Via InvestorPlace

Rag to Riches: 3 Penny Stocks That Could Make Early Investors Rich ↗

June 20, 2024

These are the penny stocks to buy, representing businesses with a promising growth outlook for the long term.

Via InvestorPlace

3 Penny Stocks to Turn $50,000 Into $1 Million: June 2024 ↗

June 17, 2024

These are undervalued penny stocks to buy as they represent companies with the likelihood of multi-fold growth in revenue.

Via InvestorPlace

Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 ↗

June 10, 2024

These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news

Via InvestorPlace

Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar ↗

June 07, 2024

These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials.

Via InvestorPlace

The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom ↗

May 23, 2024

These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress.

Via InvestorPlace

ENTX Stock Earnings: Entera Bio Beats EPS for Q1 2024 ↗

May 10, 2024

ENTX stock results show that Entera Bio beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? ↗

April 15, 2024

Discover three biotech stocks with explosive growth potential. Don't miss out on these great picks this year.

Via InvestorPlace

Entera Bio And 3 Other Stocks Under $1 Insiders Are Buying ↗

January 12, 2024

The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...

Via Benzinga

Topics Stocks

Bioventus And 3 Other Stocks Under $5 Insiders Are Buying ↗

August 23, 2023

The Dow Jones closed lower by 175 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...

Via Benzinga

Topics Stocks

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 07, 2023

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the...

Via Benzinga

Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket ↗

March 07, 2023

Gainers

Via Benzinga

Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 06, 2023

Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.